Elsevier

Clinics in Liver Disease

Volume 23, Issue 3, August 2019, Pages 535-555
Clinics in Liver Disease

Drugs in the Pipeline for HBV

https://doi.org/10.1016/j.cld.2019.04.006Get rights and content
Under a Creative Commons license
open access

Keywords

HBV cure
cccDNA
Core protein inhibitor
siRNA
Entry inhibitor
TLR agonist
Immunotherapy

Cited by (0)

Disclosure Statement: U. Lopatin is an employee of Assembly Biosciences.